arginyl-glycyl-aspartic acid has been researched along with Impaired Glucose Tolerance in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brenmoehl, J; Hoeflich, A; Kunze, M; Ohde, D; Reyer, A; Schindler, N; Tuchscherer, A; Walz, C; Wirthgen, E | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Impaired Glucose Tolerance
Article | Year |
---|---|
The RGD sequence present in IGFBP-2 is required for reduced glucose clearance after oral glucose administration in female transgenic mice.
Topics: Administration, Oral; Animals; Blood Glucose; Carbohydrate Metabolism; Female; Glucose; Glucose Intolerance; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin-Like Growth Factor Binding Protein 2; Mice; Mice, Transgenic; Oligopeptides; Protein Transport | 2015 |